Skip to main content


  • Friday, Mar 8th
    12:30 PM – 6:30 PM ET
    CSRC at CRT Think Tank: Cardiogenic Shock VIII in Person [Non-CME]
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    12:30 PM – 12:35 PM ET
    Welcome and Introduction
    Location: Monroe
    Speaker: Norman Stockbridge, MD, PhD – FDA/CDER
    Symposium
  • Friday, Mar 8th
    12:30 PM – 12:45 PM ET
    WELCOME & OVERVIEW OF CSRC CARDIOGENIC SHOCK PROGRAM
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    12:35 PM – 12:45 PM ET
    Overview of the CSRC Shock Program 2017-2024
    Location: Monroe
    Speaker: Mitchell Krucoff, MD, FACC – Duke University Medical Center/Duke Clinical Research Institute
    Symposium
  • Friday, Mar 8th
    12:45 PM – 1:05 PM ET
    Plenary Presentation: Shock Outcomes 2024 -- Recent Data, What’s Missing and Where to Go From Here?
    Location: Monroe
    Speaker: Navin K. Kapur, MD, FSCAI FAHA FACC – Tufts Medical Center
    Symposium
  • Friday, Mar 8th
    12:45 PM – 2:15 PM ET
    SESSION I: KEY UPDATES IN MCS FOR CARDIOGENIC SHOCK
    Location: Monroe
    Moderator: Kathleen Grunder
    Moderator: Mitchell Krucoff, MD, FACC – Duke University Medical Center/Duke Clinical Research Institute
    Symposium
  • Friday, Mar 8th
    1:05 PM – 1:15 PM ET
    Final report—CSRC SHARC Working Group
    Location: Monroe
    Speaker: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
    Symposium
  • Friday, Mar 8th
    1:15 PM – 1:25 PM ET
    Priority Questions for MCS in 2024: An FDA Perspective
    Location: Monroe
    Speaker: Mauro Moscucci, MD, MBA, MPH – Food and Drug Administration, Center for Devices and Radiological Health
    Symposium
  • Friday, Mar 8th
    1:25 PM – 2:15 PM ET
    Discussion: Priorities for Collaboration & Cardiogenic Shock Evidence 2024
    Location: Monroe
    Panel Moderator: Kathleen Grunder
    Panel Moderator: Mitchell Krucoff, MD, FACC – Duke University Medical Center/Duke Clinical Research Institute
    Panel Discussant: Nicole Gillette – FDA
    Panel Discussant: Timothy D. Henry, MD – The Christ Hospital
    Panel Discussant: Mariell Jessup
    Panel Discussant: Harish Lecamwasam
    Panel Discussant: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
    Panel Discussant: Ernest Spitzer, MD – Cardialysis B.V.
    Symposium
  • Friday, Mar 8th
    2:15 PM – 2:25 PM ET
    Overview of the FDA DEI Draft Guidance
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    2:15 PM – 3:45 PM ET
    SESSION II: DIVERSITY, EQUITY AND INCLUSIVENESS (DEI): CHALLENGES AND PRAGMATIC PATHWAYS IN CARDIOGENIC SHOCK
    Location: Monroe
    Moderator: Dominic Allocco, MD, MS – Boston Scientific
    Moderator: Timothy D. Henry, MD – The Christ Hospital
    Symposium
  • Friday, Mar 8th
    2:25 PM – 2:35 PM ET
    What Do We Know About Shock Research and DEI
    Location: Monroe
    Speaker: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
    Symposium
  • Friday, Mar 8th
    2:35 PM – 2:45 PM ET
    "DEI 101" for MCS Device Studies - What Do We Do, How Do We Define "Success"?
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    2:45 PM – 2:55 PM ET
    Considerations for Consent, EFIC and DEI in Shock Studies
    Location: Monroe
    Speaker: Karen Adams
    Symposium
  • Friday, Mar 8th
    2:55 PM – 3:05 PM ET
    How Could the AHA Shock Registry Support DEI in Shock Research
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    3:05 PM – 3:45 PM ET
    Discussion: Priorities for Structured DEI Enhancement in Shock Studies
    Location: Monroe
    Panel Moderator: Dominic Allocco, MD, MS – Boston Scientific
    Panel Moderator: Timothy D. Henry, MD – The Christ Hospital
    Panel Discussant: Andrew D. Althouse, PhD – Medtronic
    Panel Discussant: Paul Coplan
    Panel Discussant: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute
    Panel Discussant: Andrew Farb, MD – U.S. Food and Drug Administration
    Panel Discussant: Mariell Jessup
    Symposium
  • Friday, Mar 8th
    3:45 PM – 4:15 PM ET
    BREAK
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    4:15 PM – 4:25 PM ET
    AHA Cardiogenic Shock Registry Update & Current Status
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    4:15 PM – 5:45 PM ET
    SESSION III: RESOURCES WORKING GROUP UPDATE: THE AHA SHOCK REGISTRY 2024
    Location: Monroe
    Moderator: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
    Moderator: Nicole Gillette – FDA
    Symposium
  • Friday, Mar 8th
    4:25 PM – 4:35 PM ET
    AHA Shock Registry Collaboration: What Does It Feel Like for Industry?
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    4:35 PM – 4:45 PM ET
    AHA Shock Registry Safety Event Reporting Validation Study
    Location: Monroe
    Speaker: Andrew D. Althouse, PhD – Medtronic
    Symposium
  • Friday, Mar 8th
    4:45 PM – 4:55 PM ET
    Site-Registry Digital Interoperability: Improving Quality, Reducing Site Work –How Far Can We Go?
    Location: Monroe
    Speaker: Shashank S. Sinha, MD, MSc – Inova Heart and Vascular Institute
    Symposium
  • Friday, Mar 8th
    4:55 PM – 5:45 PM ET
    Discussion: Priorities for Registry-Based Shock Evidence 2024
    Location: Monroe
    Panel Moderator: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
    Panel Moderator: Nicole Gillette – FDA
    Panel Discussant: Andrew D. Althouse, PhD – Medtronic
    Panel Discussant: Mariell Jessup
    Panel Discussant: Mitchell Krucoff, MD, FACC – Duke University Medical Center/Duke Clinical Research Institute
    Panel Discussant: Harish Lecamwasam
    Panel Discussant: Mauro Moscucci, MD, MBA, MPH – Food and Drug Administration, Center for Devices and Radiological Health
    Panel Discussant: Christine Rutan
    Panel Discussant: Shashank S. Sinha, MD, MSc – Inova Heart and Vascular Institute
    Symposium
  • Friday, Mar 8th
    5:45 PM – 6:30 PM ET
    Discussion: What Directions and Working Groups Best Fit Shock Evidence Priorities for 2024?
    Location: Monroe
    Moderator: Bram Zuckerman, MD – U.S. Food and Drug Administration
    Moderator: Mitchell Krucoff, MD, FACC – Duke University Medical Center/Duke Clinical Research Institute
    Panel Discussant: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
    Panel Discussant: Andrew Farb, MD – U.S. Food and Drug Administration
    Panel Discussant: Nicole Gillette – FDA
    Panel Discussant: Mariell Jessup
    Panel Discussant: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
    Symposium
  • Friday, Mar 8th
    5:45 PM – 6:30 PM ET
    SESSION IV: PRIORITY 2024 DIRECTIONS & WORKING GROUPS GOING FORWARD
    Location: Monroe
    Symposium
  • Friday, Mar 8th
    6:30 PM ET
    Adjourn
    Location: Monroe
    Symposium